MedTrace Logo

A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis

NCT02445807 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 265

Last updated 2018-05-15

Study results available
· View outcomes & findings →

Summary

This study will compare the efficacy and safety of DFD-06 Cream to Vehicle Cream for topical treatment of moderate to severe plaque psoriasis after 3, 7, and 14 days of treatment.

Conditions

  • Chronic Stable Plaque Psoriasis

Interventions

DRUG

DFD06-Cream

Twice daily topical application for 14 days.

DRUG

Vehicle Cream

Twice daily topical application for 14 days.

Sponsors & Collaborators

  • Promius Pharma, LLC

    lead INDUSTRY

Principal Investigators

  • Srinivas Sidgiddi, MD · Dr Reddy's Laboratories Inc

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2016-07-31
Completion
2016-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02445807 on ClinicalTrials.gov